NYSE:MMM - 3M Stock Price, Price Target & More

3M trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMM."

3M announced a quarterly dividend on Tuesday, May 8th. Stockholders of record on Friday, May 18th will be paid a dividend of $1.36 per share on Tuesday, June 12th. This represents a $5.44 dividend on an annualized basis and a dividend yield of 2.71%. The ex-dividend date is Thursday, May 17th. View 3M's Dividend History.

3M Co (NYSE:MMM) announced its earnings results on Tuesday, April, 24th. The conglomerate reported $2.50 earnings per share (EPS) for the quarter, meeting the Zacks' consensus estimate of $2.50. The conglomerate earned $8.28 billion during the quarter, compared to analyst estimates of $8.21 billion. 3M had a net margin of 12.83% and a return on equity of 50.11%. The business's revenue was up 7.7% compared to the same quarter last year. During the same period last year, the company posted $2.16 earnings per share. View 3M's Earnings History.

3M is scheduled to release their next quarterly earnings announcement on Tuesday, July, 24th 2018. View Earnings Estimates for 3M.

3M updated its FY18 earnings guidance on Tuesday, April, 24th. The company provided earnings per share guidance of $10.20-10.55 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $10.54.

16 equities research analysts have issued twelve-month price objectives for 3M's shares. Their predictions range from $200.00 to $285.00. On average, they expect 3M's share price to reach $229.6667 in the next year. This suggests a possible upside of 14.4% from the stock's current price. View Analyst Ratings for 3M.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 3M in the last year. There are currently 4 sell ratings, 5 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to 3M include Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), Baxter International (BAX), ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), Dexcom (DXCM), ICU Medical (ICUI), Hill-Rom (HRC), Globus Medical (GMED), Insulet (PODD), Haemonetics (HAE) and Penumbra (PEN).

Headlines about MMM stock have trended somewhat positive on Tuesday, Accern Sentiment reports. Accern rates the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. 3M earned a daily sentiment score of 0.09 on Accern's scale. They also gave media headlines about the conglomerate an impact score of 47.00 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

3M's stock is owned by many different of institutional and retail investors. Top institutional investors include Confluence Investment Management LLC (0.09%), Swedbank (0.09%), Alecta Pensionsforsakring Omsesidigt (0.08%), Gateway Investment Advisers LLC (0.06%), Welch & Forbes LLC (0.04%) and Gulf International Bank UK Ltd (0.03%). Company insiders that own 3M stock include Eric D Hammes, Frank R Jr Little, Hak Cheol Shin, Inge G Thulin, Ippocratis Vrohidis, Ivan K Fong, James L Bauman, Jon T Lindekugel, Julie L Bushman, Khandpur K Ashish, Kimberly F Price, Marlene Mary Mcgrath, Michael F Roman, Nicholas C Gangestad and Paul A Keel. View Institutional Ownership Trends for 3M.

MMM stock was sold by a variety of institutional investors in the last quarter, including Sabal Trust CO, Capital One National Association, NN Investment Partners Holdings N.V., Radnor Capital Management LLC, Manning & Napier Group LLC, Fjarde AP Fonden Fourth Swedish National Pension Fund, Riverbridge Partners LLC and Fisher Asset Management LLC. Company insiders that have sold 3M company stock in the last year include Eric D Hammes, Frank R Jr Little, Hak Cheol Shin, Inge G Thulin, Ippocratis Vrohidis, Ivan K Fong, James L Bauman, Jon T Lindekugel, Khandpur K Ashish, Michael F Roman, Nicholas C Gangestad and Paul A Keel. View Insider Buying and Selling for 3M.

MMM stock was purchased by a variety of institutional investors in the last quarter, including Alecta Pensionsforsakring Omsesidigt, Confluence Investment Management LLC, State of Alaska Department of Revenue, Gofen & Glossberg LLC IL, Benson Investment Management Company Inc., Park National Corp OH, LGT Capital Partners LTD. and Addenda Capital Inc.. View Insider Buying and Selling for 3M.

Shares of MMM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MMM stock can currently be purchased for approximately $200.75.

3M has a market capitalization of $119.44 billion and generates $31.66 billion in revenue each year. The conglomerate earns $4.86 billion in net income (profit) each year or $9.17 on an earnings per share basis. 3M employs 91,536 workers across the globe.

3M's mailing address is 3M CENTER BLDG. 220-11W-02, ST PAUL MN, 55144. The conglomerate can be reached via phone at 651-733-1110.